298 related articles for article (PubMed ID: 35753869)
1. COVID-19, vaccines and deficiency of ACE
Angeli F; Reboldi G; Trapasso M; Zappa M; Spanevello A; Verdecchia P
Eur J Intern Med; 2022 Sep; 103():23-28. PubMed ID: 35753869
[TBL] [Abstract][Full Text] [Related]
2. The spike effect of acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 vaccines on blood pressure.
Angeli F; Zappa M; Reboldi G; Gentile G; Trapasso M; Spanevello A; Verdecchia P
Eur J Intern Med; 2023 Mar; 109():12-21. PubMed ID: 36528504
[TBL] [Abstract][Full Text] [Related]
3. Hypothesis for renin-angiotensin inhibitor mitigation of COVID-19.
Sackin H
Med Hypotheses; 2021 Jul; 152():110609. PubMed ID: 34048987
[TBL] [Abstract][Full Text] [Related]
4. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
Cheng H; Wang Y; Wang GQ
J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
[TBL] [Abstract][Full Text] [Related]
5. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.
Verdecchia P; Cavallini C; Spanevello A; Angeli F
Eur J Intern Med; 2020 Jun; 76():14-20. PubMed ID: 32336612
[TBL] [Abstract][Full Text] [Related]
6. Two hits to the renin-angiotensin system may play a key role in severe COVID-19.
Tseng YH; Yang RC; Lu TS
Kaohsiung J Med Sci; 2020 Jun; 36(6):389-392. PubMed ID: 32492292
[TBL] [Abstract][Full Text] [Related]
7. Spike-mediated ACE2 down-regulation was involved in the pathogenesis of SARS-CoV-2 infection.
Gao X; Zhang S; Gou J; Wen Y; Fan L; Zhou J; Zhou G; Xu G; Zhang Z
J Infect; 2022 Oct; 85(4):418-427. PubMed ID: 35793758
[TBL] [Abstract][Full Text] [Related]
8. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
9. ApoE4 associated with severe COVID-19 outcomes via downregulation of ACE2 and imbalanced RAS pathway.
Chen F; Chen Y; Ke Q; Wang Y; Gong Z; Chen X; Cai Y; Li S; Sun Y; Peng X; Ji Y; Zhang T; Wu W; Cui L; Wang Y
J Transl Med; 2023 Feb; 21(1):103. PubMed ID: 36759834
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 vaccines: Lights and shadows.
Angeli F; Spanevello A; Reboldi G; Visca D; Verdecchia P
Eur J Intern Med; 2021 Jun; 88():1-8. PubMed ID: 33966930
[TBL] [Abstract][Full Text] [Related]
11. [Hypertension after COVID-19 vaccination].
Angeli F; Reboldi G; Trapasso M; Verdecchia P
G Ital Cardiol (Rome); 2022 Jan; 23(1):10-14. PubMed ID: 34985455
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
Kuba K; Yamaguchi T; Penninger JM
Front Immunol; 2021; 12():732690. PubMed ID: 35003058
[TBL] [Abstract][Full Text] [Related]
13. Molecular Mimicry of the Viral Spike in the SARS-CoV-2 Vaccine Possibly Triggers Transient Dysregulation of ACE2, Leading to Vascular and Coagulation Dysfunction Similar to SARS-CoV-2 Infection.
Devaux CA; Camoin-Jau L
Viruses; 2023 Apr; 15(5):. PubMed ID: 37243131
[TBL] [Abstract][Full Text] [Related]
14. A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19.
Malek Mahdavi A
Rev Med Virol; 2020 Sep; 30(5):e2119. PubMed ID: 32584474
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.
Shukla AK; Banerjee M
High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533
[TBL] [Abstract][Full Text] [Related]
16. Relationship Between ACE2 and Other Components of the Renin-Angiotensin System.
Cohen JB; Hanff TC; Bress AP; South AM
Curr Hypertens Rep; 2020 Jun; 22(7):44. PubMed ID: 32591908
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes.
Obukhov AG; Stevens BR; Prasad R; Li Calzi S; Boulton ME; Raizada MK; Oudit GY; Grant MB
Diabetes; 2020 Sep; 69(9):1875-1886. PubMed ID: 32669391
[TBL] [Abstract][Full Text] [Related]
18. Repressed Ang 1-7 in COVID-19 Is Inversely Associated with Inflammation and Coagulation.
Carpenter RM; Young MK; Petri WAO; Lyons GR; Gilchrist C; Carey RM; Petri WA
mSphere; 2022 Aug; 7(4):e0022022. PubMed ID: 35913134
[TBL] [Abstract][Full Text] [Related]
19. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection.
Beyerstedt S; Casaro EB; Rangel ÉB
Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):905-919. PubMed ID: 33389262
[TBL] [Abstract][Full Text] [Related]
20. Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System.
Costa LB; Perez LG; Palmeira VA; Macedo E Cordeiro T; Ribeiro VT; Lanza K; Simões E Silva AC
Front Cell Dev Biol; 2020; 8():559841. PubMed ID: 33042994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
